Cargando…
Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study
AIMS: Aim was to assess the feasibility of serum markers to identify individuals at risk for gastro-oesophageal adenocarcinoma to reduce the number of individuals requiring invasive assessment by endoscopy. METHODS: Blood samples from 56 patients with Barrett’s oesophagus and 202 non-Barrett control...
Autores principales: | Xu, Yiwang, Miremadi, Ahmad, Link, Alexander, Malfertheiner, Peter, Fitzgerald, Rebecca C, Bornschein, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874497/ https://www.ncbi.nlm.nih.gov/pubmed/31235543 http://dx.doi.org/10.1136/jclinpath-2019-205700 |
Ejemplares similares
-
Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic
por: di Pietro, Massimiliano, et al.
Publicado: (2020) -
Early Diagnosis of Gastroesophageal Cancers and the Cytosponge: A Work in Progress
por: Fitzgerald, Rebecca C., et al.
Publicado: (2017) -
Detecting Barrett oesophagus using Cytosponge
por: Hindson, Jordan
Publicado: (2020) -
Cytosponge-TFF3 Testing can Detect Precancerous Mucosal Changes of the Stomach
por: Hadjinicolaou, ANDREAS V., et al.
Publicado: (2022) -
Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samples
por: Masqué-Soler, Neus, et al.
Publicado: (2022)